ANTH:Anthera Pharmaceuticals Inc - Stock Price Quote and Dividend Data
LATEST CLOSE STOCK PRICE
$0.04
EXCHANGE
OTCBB
SECTOR / SEGMENT / INDUSTRY
Health Care / Pharmaceuticals & Biotechnology / Biotechnology
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend Paid1970
52-Week Low/High Stock Price$0.01 - $0.06
Percent Held by Institutions5.35%
Revenue$0
Net Income$-31,115,000
Cash Flow$-9,381,000
EPS-0.42%
Market Cap$998,598
PE Ratio to Industry60%
Debt-Equity Ratio0.00%
Debt-Equity to Industry1.16%
Total Return Last 12 Months-1.99%
Total Return Last 3 Years-97.96%
Total Return Last 5 Years-99.85%
Latest Trade DateJan. 26, 2021
No Data available for Payment History.
Anthera Pharmaceuticals is a biopharmaceutical company focused on advancing the development and commercialization of medicines that benefit patients with medical needs. Co. has two compounds in development, Sollpura and blisibimod. Sollpura is a non-porcine investigational Pancreatic Enzyme Replacement Therapy intended for the treatment of patients with Exocrine Pancreatic Insufficiency, often seen in patients with cystic fibrosis and other conditions. Blisibimod targets B-cell activating factor, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy.
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryBiotechnology
Dividend AllStar™ Ranking
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Jan. 14, 2021STOCK PRICE DECREASE: Anthera Pharmaceuticals Inc (OTCBB: ANTH) on 01-14-2021 decreased stock price > 10% from $0.05 to $0.04
Jan. 13, 2021STOCK PRICE INCREASE: Anthera Pharmaceuticals Inc (OTCBB: ANTH) on 01-13-2021 increased stock price > 10% from $0.02 to $0.05
Dec. 18, 2020STOCK PRICE INCREASE: Anthera Pharmaceuticals Inc (OTCBB: ANTH) on 12-18-2020 increased stock price > 10% from $0.01 to $0.02
Oct. 03, 2020CLOSE PRICE DECREASE: Anthera Pharmaceuticals Inc (OTCBB: ANTH) on 10-03-2020 decreased close price > 10% from $0.03 to $0.02
Sep. 18, 2020CLOSE PRICE DECREASE: Anthera Pharmaceuticals Inc (OTCBB: ANTH) on 09-18-2020 decreased close price > 10% from $0.03 to $0.03
Sep. 17, 2020CLOSE PRICE INCREASE: Anthera Pharmaceuticals Inc (OTCBB: ANTH) on 09-17-2020 increased close price > 10% from $0.03 to $0.03
Sep. 12, 2020CLOSE PRICE DECREASE: Anthera Pharmaceuticals Inc (OTCBB: ANTH) on 09-12-2020 decreased close price > 10% from $0.03 to $0.03
Aug. 15, 2020CLOSE PRICE INCREASE: Anthera Pharmaceuticals Inc (OTCBB: ANTH) on 08-15-2020 increased close price > 10% from $0.03 to $0.03
Aug. 13, 2020CLOSE PRICE INCREASE: Anthera Pharmaceuticals Inc (OTCBB: ANTH) on 08-13-2020 increased close price > 10% from $0.03 to $0.03
Aug. 11, 2020CLOSE PRICE DECREASE: Anthera Pharmaceuticals Inc (OTCBB: ANTH) on 08-11-2020 decreased close price > 10% from $0.04 to $0.03
Jan. 27, 2021STOCK PRICE DECREASE: Viridian Therapeutics Inc (NASDAQ: VRDN) on 01-27-2021 decreased stock price > 10% from $22.26 to $19.87
Jan. 27, 2021STOCK PRICE DECREASE: Twist Bioscience Corp (NASDAQ: TWST) on 01-27-2021 decreased stock price > 10% from $186.04 to $162.82
Jan. 27, 2021STOCK PRICE DECREASE: Reneuron Group plc (OTCBB: RNUGF) on 01-27-2021 decreased stock price > 10% from $1.78 to $1.58
Jan. 27, 2021STOCK PRICE DECREASE: Response Genetics Inc (OTCBB: RGDXQ) on 01-27-2021 decreased stock price > 10% from $0.01 to $0.00
Jan. 27, 2021STOCK PRICE DECREASE: Replimune Group Inc (NASDAQ: REPL) on 01-27-2021 decreased stock price > 10% from $45.04 to $39.41
Jan. 27, 2021STOCK PRICE DECREASE: Predictive Technology Group Inc (OTCBB: PRED) on 01-27-2021 decreased stock price > 10% from $0.12 to $0.11
Jan. 27, 2021STOCK PRICE DECREASE: Poniard Pharmaceuticals Inc (OTCBB: PARD) on 01-27-2021 decreased stock price > 10% from $0.09 to $0.03
Jan. 27, 2021STOCK PRICE DECREASE: OncBioMune Pharmaceuticals Inc (OTCBB: OBMP) on 01-27-2021 decreased stock price > 10% from $0.23 to $0.14
Jan. 27, 2021STOCK PRICE DECREASE: Intellia Therapeutics Inc (NASDAQ: NTLA) on 01-27-2021 decreased stock price > 10% from $71.40 to $64.25
Jan. 27, 2021STOCK PRICE DECREASE: NanoString Technologies Inc (NASDAQ: NSTG) on 01-27-2021 decreased stock price > 10% from $77.03 to $68.96